Zurcher Kantonalbank (Zurich Cantonalbank) Replimune Group, Inc. Transaction History
Zurcher Kantonalbank (Zurich Cantonalbank)
- $33.8 Billion
- Q1 2025
A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Replimune Group, Inc. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 11,410 shares of REPL stock, worth $109,193. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,410
Previous 5,534
106.18%
Holding current value
$109,193
Previous $67,000
65.67%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding REPL
# of Institutions
172Shares Held
78.5MCall Options Held
69.4KPut Options Held
216K-
Baker Bros. Advisors LP New York, NY11MShares$106 Million1.28% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.9MShares$104 Million0.01% of portfolio
-
Redmile Group, LLC San Francisco, CA4.9MShares$46.9 Million5.02% of portfolio
-
Black Rock Inc. New York, NY4.71MShares$45.1 Million0.0% of portfolio
-
Fcpm Iii Services B.V. Naarden, P73.91MShares$37.4 Million9.21% of portfolio
About Replimune Group, Inc.
- Ticker REPL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,306,700
- Market Cap $472M
- Description
- Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...